These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9096646)

  • 1. Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators.
    Malats N; Porta M; Corominas JM; Piñol JL; Rifà J; Real FX
    Int J Cancer; 1997 Mar; 70(6):661-7. PubMed ID: 9096646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
    Porta M; Malats N; Guarner L; Carrato A; Rifà J; Salas A; Corominas JM; Andreu M; Real FX
    J Epidemiol Community Health; 1999 Nov; 53(11):702-9. PubMed ID: 10656099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.
    Malats N; Porta M; Piñol JL; Corominas JM; Rifà J; Real FX
    J Clin Oncol; 1995 Jul; 13(7):1679-86. PubMed ID: 7602358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
    Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
    Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer.
    Crous-Bou M; Porta M; López T; Jariod M; Malats N; Alguacil J; Morales E; Fernandez E; Corominas JM; Carrato A; Guarner L; Real FX;
    Pancreas; 2007 Aug; 35(2):135-41. PubMed ID: 17632319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalizing molecular results arising from incomplete biological samples: expected bias and unexpected findings.
    Porta M; Malats N; Corominas JM; Rifà J; Piñol JL; Real FX;
    Ann Epidemiol; 2002 Jan; 12(1):7-14. PubMed ID: 11750234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
    Porta M; Malats N; Jariod M; Grimalt JO; Rifà J; Carrato A; Guarner L; Salas A; Santiago-Silva M; Corominas JM; Andreu M; Real FX
    Lancet; 1999 Dec 18-25; 354(9196):2125-9. PubMed ID: 10609819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma.
    Crous-Bou M; Porta M; López T; Jariod M; Malats N; Morales E; Guarner L; Rifà J; Carrato A; Real FX;
    Environ Mol Mutagen; 2009 Jun; 50(5):421-30. PubMed ID: 19326463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
    Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
    Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer.
    Alguacil J; Porta M; Kauppinen T; Malats N; Kogevinas M; Carrato A;
    Int J Cancer; 2003 Nov; 107(4):635-41. PubMed ID: 14520703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
    Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
    Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
    Abbruzzese JL; Evans DB; Raijman I; Larry L; King T; Leach SD; Frazier ML
    Anticancer Res; 1997; 17(2A):795-801. PubMed ID: 9137410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
    Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Ki-ras mutations in peripheral blood of pancreatic cancer patients: a marker for early tumor metastasis.
    Mohiuddin M; Ahmed MM; Venkatasubbarao K
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):161-6. PubMed ID: 12118546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
    Pellegata NS; Sessa F; Renault B; Bonato M; Leone BE; Solcia E; Ranzani GN
    Cancer Res; 1994 Mar; 54(6):1556-60. PubMed ID: 8137263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency of K-ras mutation in biliary and pancreatic tumors].
    Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
    Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of codon 12 mutation in the K-ras oncogene in pancreatic tumors.
    Kubrusly MS; Matheucci Júnior E; Leite KR; Coelho AM; Monte O; Machado MC; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1999; 54(1):17-20. PubMed ID: 10488596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer.
    Alguacil J; Porta M; Malats N; Kauppinen T; Kogevinas M; Benavides FG; Partanen T; Carrato A;
    Carcinogenesis; 2002 Jan; 23(1):101-6. PubMed ID: 11756230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.